Vera Therapeutics

#5040

Rank

$1.35B

Marketcap

United States

Country

Leadership team

Dr. Marshall Fordyce M.D. (Founder, Pres, CEO & Director)

Mr. Sean P. Grant M.B.A. (Chief Financial Officer)

Dr. Celia Lin M.D. (Chief Medical Officer)

Products/ Services

Biotechnology, Health Care

Headquarters

South San Francisco, California, United States

Established

2016

Company Registration

SEC CIK number: 0001831828

Traded as

VERA

Social Media

URL

https://veratx.com

Overview

Location

Recognition and Award

References

Summary

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections and is under Phase 2 clinical trial. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.

History

Vera Therapeutics was founded in 2015 by three experienced scientists and healthcare professionals. The company's mission is to develop therapies that will make a meaningful impact in the lives of those suffering from age-related diseases and disorders. Since its founding, the company has secured investments from top investors and developed a strong portfolio of products and technologies to achieve its goal.

Mission

Vera Therapeutics is dedicated to developing new therapies that have the potential to dramatically improve the lives of individuals with age-related diseases and disorders.

Vision

Vera Therapeutics is committed to becoming the leading provider of innovative therapies and technologies for aging-related diseases and disorders.

Key Team

Mr. Tom Doan (Sr. VP of Devel. Operations)

Ms. Lauren Frenz (Chief Bus. Officer)

Mr. Joseph R. Young M.B.A. (Sr. VP of Fin. & Chief Accounting Officer)

Dr. Joanne Curley Ph.D. (Chief Devel. Officer)

Mr. Julien E. Capers J.D. (VP & Head of Legal)

Dr. Neeraj Pakala M.B.A., Ph.D. (Sr. VP of Product Devel. & Manufacturing)

Ms. Kelly Rauber (VP & Head of HR)

Recognition and Awards

Vera Therapeutics has earned numerous awards, including the 2018 Bio-Entrepreneur of the Year Award from the Global Biotechnology Innovation Network and the 2018 Forbes 30 Under 30 in Medical and Health Innovation Award.